INVESTOR NEWS

Feb 15, 2023

New study addresses the use of plasma calprotectin in sepsis management

Moss, 15 February 2023

Aug 29, 2022

Mandatory notification of trade

Moss, 29 August 2022

Aug 26, 2022

Mandatory notification of trade

Moss, 26 August 2022

Aug 25, 2022

Second quarter 2022 report

Moss, 25 August 2022 Gentian Diagnostics ASA, a fast-growing developer and manufacturer of diagnostic tests,..

Aug 23, 2022

Gentian Diagnostics signs distribution agreement for Cystatin C

Gentian Diagnostics ASA, a fast-growing developer and manufacturer of innovative and efficient diagnostics,..

Aug 18, 2022

Invitation to presentation of second quarter results

Gentian Diagnostics ASA will present its second quarter 2022 results on August 25th at 10.00 am.